Purging (Eating Disorders)
7
3
3
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
14.3%
1 terminated out of 7 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Targeting Social Function in Anxiety and Eating Disorders
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
Naltrexone Neuroimaging in Teens With Eating Disorders
Oral Naltrexone In Pediatric Eating Disorders
Naltrexone Neuroimaging
Emotion Regulation in Binge Eating and Purging Among Adolescents
Improving Treatments for Bulimia Nervosa: Innovation in Psychological Interventions for Regulating Eating